Hypergonadotropic hypogonadism after ovarian tissue cryopreservation on a 13-year-old female: A case report and review of the literature.

Fertility preservation Gonadotoxic treatment Hypergonadotropic hypogonadism Oncofertility Ovarian failure Ovarian tissue cryopreservation

Journal

Journal of gynecology obstetrics and human reproduction
ISSN: 2468-7847
Titre abrégé: J Gynecol Obstet Hum Reprod
Pays: France
ID NLM: 101701588

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 10 10 2020
revised: 20 11 2020
accepted: 24 11 2020
pubmed: 2 12 2020
medline: 25 2 2023
entrez: 1 12 2020
Statut: ppublish

Résumé

Ovarian failure is a major long-term adverse event following gonadotoxic treatment of malignant diseases. Ovarian tissue cryopreservation can be offered in some conditions to preserve fertility. We report the case of a 13-year-old female with a diagnosis of acute myeloid leukemia, who presented with hypergonadotropic hypogonadism after unilateral ovariectomy for fertility preservation and before highly gonadotoxic treatment. Even though damage seemed only partial, this case suggests that the remaining contralateral ovarian function may be compromised after ovarian tissue cryopreservation, leading per se to a hypergonadotropic hypogonadism. Although indication of ovarian cryopreservation is not called into question in situations of highly gonadotoxic therapy, this procedure should only be performed after evaluation by a specialized multidisciplinary team and provided a solid indication.

Identifiants

pubmed: 33259962
pii: S2468-7847(20)30405-0
doi: 10.1016/j.jogoh.2020.102029
pii:
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102029

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors report no declarations of interest.

Auteurs

Dehlia Moussaoui (D)

Division of General Pediatrics, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland. Electronic address: dehlia.moussaoui@hcuge.ch.

Julie Bénard (J)

Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland.

Michal Yaron (M)

Division of Gynecology, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland.

Fanette Bernard (F)

Pediatric Onco-Hematology Unit, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland; CANSEARCH Research Laboratory, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Cécile Adam (C)

Division of Pediatrics, Oncology and Hematology Unit, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland.

Nicolas Vulliemoz (N)

Fertility Medicine and Gynecologic Endocrinology Unit, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland.

Thérèse Bouthors (T)

Division of Pediatrics, Pediatric Endocrinology and Diabetology Unit, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland.

Véronique Andrey (V)

Division of Pediatric Surgery, Woman-Mother-Child Department, Lausanne University Hospital, Lausanne, Switzerland.

Marc Ansari (M)

Pediatric Onco-Hematology Unit, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland; CANSEARCH Research Laboratory, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Céline Girardin (C)

Pediatric Endocrine and Diabetes Unit, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland.

Fabienne Gumy-Pause (F)

Pediatric Onco-Hematology Unit, Department of Woman, Child and Adolescent Medicine, Geneva University Hospitals, Geneva, Switzerland; CANSEARCH Research Laboratory, Department of Woman, Child and Adolescent Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH